Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82.8K Buy
1,319
+1,108
+525% +$77.2K 0.01% 545
2025
Q4
$14K Sell
211
-858
-80% -$55.5K ﹤0.01% 1219
2025
Q3
$71.9K Buy
+1,069
New +$84.6K 0.02% 649
2025
Q1
Sell
-1,283
Closed -$99.8K 1721
2024
Q4
$99.8K Sell
1,283
-3,305
-72% -$245K 0.01% 444
2024
Q3
$308K Buy
4,588
+4,538
+9,076% +$373K 0.08% 185
2024
Q2
$5.67K Sell
50
-3,812
-99% -$482K ﹤0.01% 1470
2024
Q1
$536K Buy
3,862
+3,597
+1,357% +$452K 0.1% 142
2023
Q4
$32.9K Sell
265
-551
-68% -$56.3K 0.01% 499
2023
Q3
$76.1K Buy
816
+634
+348% +$71.5K 0.02% 241
2023
Q2
$23.4K Buy
182
+60
+49% +$7.26K 0.01% 511
2023
Q1
$14.2K Buy
+122
New +$13.7K ﹤0.01% 753

Other funds holding DXCM

Quarry LP's DXCM Position: Q1 2026 in Review

Quarry LP increased its DexCom (DXCM) stake by 525% in Q1 2026, buying an estimated $77.2K and bringing the position to 1,319 shares worth $82.8K. The position accounts for 0.01% of the portfolio, ranked #545.

Quarry LP first reported a position in DXCM in Q1 2023 and has held it in 11 quarters since. The position peaked at $536K in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Quarry LP held 1,319 shares of DexCom worth $82.8K as of Q1 2026.
  • Quarry LP bought 1,108 DexCom shares in Q1 2026, an estimated $77.2K.
  • DexCom made up 0.01% of Quarry LP's portfolio in Q1 2026, its #545 holding.
  • Quarry LP first reported a position in DexCom in Q1 2023 and has held it in 11 quarters since.
  • Quarry LP's DexCom position peaked at $536K in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.